Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

27.25
-0.1400-0.51%
Volume:3.85M
Turnover:105.53M
Market Cap:10.54B
PE:-2.94
High:27.87
Open:26.78
Low:26.62
Close:27.39
Loading ...

Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook

GuruFocus.com
·
19 Feb

Moderna Price Target Maintained With a $40.00/Share by RBC Capital

Dow Jones
·
19 Feb

Moderna has limited upside: Barclays

Investing.com
·
19 Feb

Top Calls on Wall Street: Nvidia, Apple, Tesla, Meta, Dell, Snowflake, Moderna, and More

Tiger Newspress
·
18 Feb

Stock Track | Moderna Soars 5.05% as Analyst Downgrade Sparks Optimism

Stock Track
·
18 Feb

Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?

Zacks
·
18 Feb

Moderna Cut to Equal-Weight From Overweight by Barclays

Dow Jones
·
18 Feb

Morgan Stanley Keeps Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
18 Feb

Stock Market News for Feb 18, 2025

Zacks
·
18 Feb

Moderna price target lowered to $32 from $34 at BofA

TIPRANKS
·
18 Feb

Barclays Downgrades Moderna to Equalweight From Overweight, Adjusts Price Target to $45 From $111

MT Newswires Live
·
18 Feb

Moderna downgraded to Equal Weight from Overweight at Barclays

TIPRANKS
·
18 Feb

RBC Capital Sticks to Its Hold Rating for Moderna (MRNA)

TIPRANKS
·
18 Feb

Bernstein Reaffirms Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
18 Feb

Moderna’s Market Position and Future Prospects: Hold Rating Reflects Cautious Stance Amid Execution Challenges and Financial Strategies

TIPRANKS
·
18 Feb

U.S. RESEARCH ROUNDUP-Boeing, Philip Morris, Walmart

Reuters
·
17 Feb

Moderna’s Earnings Call: A Year of Challenges and Strategic Growth

TIPRANKS
·
17 Feb

Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts

GuruFocus.com
·
15 Feb

Moderna Reports 2024 Loss, Eyes Future Growth

TIPRANKS
·
15 Feb

Sector Update: Health Care Stocks Decline Late Afternoon

MT Newswires Live
·
15 Feb